Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Case Report: Crying Blood.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Idowu OO;Idowu OO; Kaidonis G; Kaidonis G; Husain S; Husain S; Winn BJ
- Source:
Optometry and vision science : official publication of the American Academy of Optometry [Optom Vis Sci] 2021 Mar 01; Vol. 98 (3), pp. 217-221.
- Publication Type:
Case Reports; Journal Article; Research Support, N.I.H., Extramural; Review
- Language:
English
- Additional Information
- Source:
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8904931 Publication Model: Print Cited Medium: Internet ISSN: 1538-9235 (Electronic) Linking ISSN: 10405488 NLM ISO Abbreviation: Optom Vis Sci Subsets: MEDLINE
- Publication Information:
Publication: Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: [Baltimore, MD] : Williams & Wilkins, c1989-
- Subject Terms:
- Abstract:
Significance: Hemolacria (bloody tears) is a rare clinical presentation with varied underlying etiologies. Thorough clinical evaluation is essential to diagnosis and management.
Purpose: This study aimed to report unilateral hemolacria in a known contact lens wearer with an occult, palpebral, conjunctival pyogenic granuloma and review the literature.
Case Report: A 21-year-old female contact lens wearer presented to the clinic after three episodes of sudden painless bloody tears from the right eye. She was referred to the oculoplastic clinic for evaluation. On everting her right upper lid, a fleshy, nontender, ovoid, pedunculated mass was found attached to the palpebral conjunctiva of the right, nasal, upper tarsus. Surgical excision was performed in the office, and pathological examination of the lesion was consistent with pyogenic granuloma.
Conclusions: Unilateral hemolacria should raise clinical suspicion for a hidden conjunctival lesion such as pyogenic granuloma, although other more sinister causes of hemolacria must also be considered. Thorough evaluation including eyelid eversion is critical in identifying and managing occult conjunctival lesions.
Competing Interests: Conflict of Interest Disclosure: None of the authors have reported a financial conflict of interest.
(Copyright © 2021 American Academy of Optometry.)
- References:
Fowler BT, Kosko MG, Pegram TA, et al. Haemolacria: A Novel Approach to Lesion Localization. Orbit 2015;34:309–13.
Ho VH, Wilson MW, Linder JS, et al. Bloody Tears of Unknown Cause: Case Series and Review of the Literature. Ophthalmic Plast Reconstr Surg 2004;20:442–7.
Murube J. Bloody Tears: Historical Review and Report of a New Case. Ocul Surf 2011;9:117–25.
Iovieno A, Coassin M, Piana S, et al. A Case of Unilateral Hemolacria. Int Ophthalmol 2016;36:273–4.
Al-Towerki AA. Pyogenic Granuloma. Int Ophthalmol 1995;19:287–91.
Hamburger HA. Pyogenic Granuloma Associated with Extended Wear Contact Lenses. Eye Contact Lens 1986;12:99–100.
Horton JC, Mathers WD, Zimmerman LE. Pyogenic Granuloma of the Palpebral Conjunctiva Associated with Contact Lens Wear. Cornea 1990;9:359–61.
Dutta D, Cole N, Willcox M. Factors Influencing Bacterial Adhesion to Contact Lenses. Mol Vis 2012;18:14–21.
Jordan DR, Brownstein S, Lee-Wing M, et al. Pyogenic Granuloma Following Oculoplastic Procedures: An Imbalance in Angiogenesis Regulation?Can J Ophthalmol 2001;36:260–8.
Shields JA, Mashayekhi A, Kligman BE, et al. Vascular Tumors of the Conjunctiva in 140 Cases. Ophthalmology 2011;118:1747–53.
Oke I, Alkharashi M, Petersen RA, et al. Treatment of Ocular Pyogenic Granuloma with Topical Timolol. JAMA Ophthalmol 2017;135:383–5.
DeMaria LN, Silverman NK, Shinder R. Ophthalmic Pyogenic Granulomas Treated with Topical Timolol—Clinical Features of 17 Cases. Ophthalmic Plast Reconstr Surg 2018;34:579–82.
- Grant Information:
P30 EY002162 United States EY NEI NIH HHS
- Publication Date:
Date Created: 20210226 Date Completed: 20210716 Latest Revision: 20230823
- Publication Date:
20240829
- Accession Number:
PMC8005461
- Accession Number:
10.1097/OPX.0000000000001653
- Accession Number:
33633021
No Comments.